Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-1,458 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
N/A
398 Added 37.55%
1,458 $4,000
Q2 2021

Aug 16, 2021

BUY
N/A
1,060 New
1,060 $6,000
Q3 2020

Nov 16, 2020

SELL
N/A
-301 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
N/A
301 New
301 $2,000

Others Institutions Holding PHGE

About BiomX Inc.


  • Ticker PHGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,982,300
  • Market Cap $10.2M
  • Description
  • BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...
More about PHGE
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.